Entity
  • i-SEP

    Created in 2015
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,938
  • Activities

  • Technologies

  • Entity types

  • Location

    21 Rue La Noue Bras de Fer, 44200 Nantes, France

    Nantes

    France

  • Employees

    Scale: 11-50

    Estimated: 41

  • SIREN

    814086534
  • Engaged corporates

    10
    3 5
  • Added in Motherbase

    11 months ago
Description
  • Value proposition

    [Automatic translation follows] - Innovative Solutions & Efficiency for the Patient -

    i-SEP is a French Medtech, founded in 2015 in Nantes, specializing in perioperative autotransfusion and blood saving strategy (Patient Blood Management).

    i-SEP has developed and patented an innovative technology for separating blood components. Its ambition is to become the first laboratory to market an autotransfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures, with ergonomic and intuitive equipment.

    i-SEP works closely with leading anesthesiologist-resuscitator teams with the mission of improving patient benefit, simplifying the work of practitioners and helping to reduce healthcare costs.

    Our innovation brings significant added value compared to currently available solutions, particularly in terms of blood quality.

    i-SEP was co-founded by three partners:
    Dr. Francis Gadrat, anesthesiologist, Bertrand Chastenet, former business leader and consultant in the pharmaceutical industry, advisor to French foreign trade, and Sylvain Picot, founder of Biom’Up. i-SEP is supported by Atlanpole and a member of the Atlanpole Biotherapies competitiveness cluster.
    ------
    i-SEP is a French medtech, founded in 2015 in Nantes, specialized in perioperative cell salvage and blood saving strategy (Patient Blood Management).

    i-SEP has developed and patented an innovative technology for the separation of blood components. Its ambition is to become the first laboratory to market an autotransfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgeries, using equipment that is both ergonomic and intuitive. i-SEP works closely with reference teams of anesthetists-intensivists specialists with the aim of improving patient benefits, simplifying the work of physicians and helping to reduce healthcare costs.


    Patient Blood Management, PeriOperative Cell Recovery, Anesthesiology, MedTech, Autotransfusion, and IOCS

  • Original language

    - Innovative Solutions & Efficiency for the Patient -

    i-SEP est une Medtech française, fondée en 2015 à Nantes, spécialisée dans l’autotransfusion périopératoire et la stratégie d’épargne sanguine (Patient Blood Management).

    i-SEP a développé et breveté une technologie innovante de séparation des composants du sang. Son ambition est de devenir le premier laboratoire à commercialiser un système d’autotransfusion capable de récupérer à la fois les globules rouges et les plaquettes lors d’interventions chirurgicales hémorragiques, et ce avec un équipement ergonomique et intuitif.

    i-SEP travaille en étroite collaboration avec les équipes d’anesthésistes réanimateurs de référence avec pour missions d’améliorer le bénéfice patient, de simplifier le travail des praticiens et de contribuer à réduire les coûts de santé.

    Notre innovation apporte une valeur ajoutée significative par rapport aux solutions disponibles actuellement, notamment en terme de qualité du sang.

    i-SEP a été co-fondée par trois associés :
    Dr Francis Gadrat, médecin anesthésiste, Bertrand Chastenet, ancien chef d’entreprise et consultant dans l'industrie pharmaceutique, conseiller du commerce extérieur de la France, et Sylvain Picot, fondateur de Biom’Up. i-SEP est accompagnée par Atlanpole et membre du pôle de compétitivité Atlanpole Biothérapies.
    ------
    i-SEP is a French medtech, founded in 2015 in Nantes, specialized in perioperative cell salvage and blood saving strategy (Patient Blood Management).

    i-SEP has developed and patented an innovative technology for the separation of blood components. Its ambition is to become the first laboratory to market an autotransfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgeries, using equipment that is both ergonomic and intuitive. i-SEP works closely with reference teams of anesthetists-intensivists specialists with the aim of improving patient benefits, simplifying the work of physicians and helping to reduce healthcare costs.


    Patient Blood Management, PeriOperative Cell Recovery, Anesthesiology, MedTech, Autotransfusion, and IOCS

  • i-SEP - the alternative to allogeneic blood transfusions

    i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .i-SEP has developed and patented an innovative technology for the separation of blood components.

  • https://www.i-sep.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Le Journal des Entreprises
Le Journal des Entreprises
Media, Newspaper Publishing
Le Journal des Entreprises
Media, Newspaper Publishing
Other

27 Oct 2024


Samoa
Samoa
Architecture and Planning
Samoa
Architecture and Planning
Other

12 Jul 2024


Nantes Métropole
Nantes Métropole
Government Administration, French metropolis
Nantes Métropole
Government Administration, French metropolis
Other

12 Jul 2024


Région Pays de la Loire
Région Pays de la Loire
National and local authorities, Government Administration
Région Pays de la Loire
National and local authorities, Government Administration
Other

12 Jul 2024


Chambre de Commerce et d'Industrie de Nantes St-Nazaire
Chambre de Commerce et d'Industrie de Nantes St-Nazaire
Chamber of commerce, Government Administration
Chambre de Commerce et d'Industrie de Nantes St-Nazaire
Chamber of commerce, Government Administration
Other

12 Jul 2024


Atlanpole
Atlanpole
Business Consulting and Services
Atlanpole
Business Consulting and Services
Other

27 Oct 2024


NEFTYS
NEFTYS
Finance, Financial Services
NEFTYS
Finance, Financial Services
Other

30 Nov 2023


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

27 Oct 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

27 Oct 2024


Atlanpole Biotherapies
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

27 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics